Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive ยท Last trade price on Jul 7, 2025
Akoya Biosciences Employees
Akoya Biosciences had 205 employees as of December 31, 2024. The number of employees decreased by 125 or 37.88% compared to the previous year.
Employees
205
Change (1Y)
-125
Growth (1Y)
-37.88%
Revenue / Employee
$390,054
Profits / Employee
-$231,868
Market Cap
64.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 205 | -125 | -37.88% |
| Dec 31, 2023 | 330 | -39 | -10.57% |
| Dec 31, 2022 | 369 | 50 | 15.67% |
| Dec 31, 2021 | 319 | 150 | 88.76% |
| Dec 31, 2020 | 169 | - | - |
AKYA News
- 1 year ago - AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - PRNewsWire
- 1 year ago - Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal - PRNewsWire
- 1 year ago - Akoya Biosciences Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 1 year ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire
- 1 year ago - Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders - Business Wire
- 1 year ago - Quanterix and Akoya Biosciences Announce Amended Merger Agreement - Business Wire
- 1 year ago - Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 - GlobeNewsWire
- 1 year ago - Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas - GlobeNewsWire